Study identifies risk factors for cataracts in patients with diabetes mellitus

News
Article

Researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM.

Physician pricking finger with glucose meter on blue backdrop Image credit: ©KaterynaNovikova - adobe.stock.com

Image credit: AdobeStock/KaterynaNovikova

A research team from Romania identified a higher risk of cataract development in patients with diabetes mellitus (DM) who have had the disease for an extended period and who have had poor glycemic control in conjunction with systemic comorbidities,1 according to first author Adriana Ivanescu. She is from the Department of Second Internal Medicine Diabetes, Nutrition, Metabolic Diseases, and Systemic Rheumatology, “Victor Babes” University of Medicine and Pharmacy; and the Opticlass Ophthalmology Clinic, both in Timisoara, Romania.

Because DM is a well-known cause of visual loss, the researchers set out to determine the most important systemic risk factors associated with cataract development in patients with DM. “Considering the significant impact of cataracts on the quality of life of patients with diabetes, this study aimed to investigate the most important risk factors involved in cataract development to sensitize physicians to the importance of screening and early detection of cataracts and overall health among these patients,” the investigators stated.

A total of 319 patients with a diagnosis of DM were included in the study. The investigators analyzed the patient data retrieved from the medical charts that included the DM status, metabolic control, demographic and anthropometric indices, and generally associated comorbidities.

Data analysis

The authors reported studying the risk factors of hypertension, cardiovascular disease (CVD), chronic kidney disease (CKD), diabetic polyneuropathy (DPN), dyslipidemia, and hepatic steatosis, which were present in all the study patients.

The factors identified in the patients with cataract were the high prevalence rates of hypertension (67.6%), DPN (53.3%), and dyslipidemia (46.6%).

Among them, CKD (p < 0.001) and DPN (p = 0.019) were significant predictive factors for the probability of cataract development.

An ophthalmologic evaluation showed that diabetic retinopathy (DR) reached significance in the occurrence of cataracts. In addition, patient age and DM-related factors, such as disease duration (p < 0.001) and hemoglobin A1c values (p = 0.029), significantly increased the risk of cataracts. Smoking was self-reported by 24.8% of the patients, which also was related significantly to the occurrence of cataracts (p = 0.04).

The investigators concluded, “Our findings are consistent with those in the current literature, emphasizing that poor glycemic control and extended DM duration are the most critical risk factors for cataract development in patients with diabetes. Patients with DM are known to present with multiple associated pathologies such as hypertension, CVD, CKD, DPN, hepatic steatosis, and dyslipidemia. The present study identified CKD and DPN as the most influential comorbidities on cataract occurrence and development, whereas hepatic steatosis was linked to nuclear sclerotic cataracts. While maintaining optimal glycemic control remains a cornerstone strategy for preventing ophthalmological complications in patients with DM, early detection and management of all risk factors prevents the occurrence of vision-threatening cataracts and aids healthcare providers in obtaining better patient-related outcomes.”

Reference:
  1. Ivanescu A, Popescu S, Gaita L, et al. Risk factors for cataracts in patients with diabetes mellitus. J Clin Med. 2024;13:7005; https://doi.org/10.3390/jcm13237005
Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.